Clin2
NCT07657988Likely a fitRecruiting

Tirbanibulin for actinic keratosis on the face

Actinic Keratosis (AK)

Part of Cancer, Skin clinical trials.

This study tests a cream called tirbanibulin (Klisyri) for adults with 4 to 12 actinic keratosis (AK) spots on their face. It aims to see how well the treatment works when applied to a larger area of the face in everyday medical practice.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have actinic keratosis (AK) spots on your face
  • You have between 4 and 12 AK spots that are clearly visible
  • You are 18 years old or older
  • You are willing to use sunscreen and avoid too much sun or UV light during the study
  • You can read and write in English and agree to follow the study procedures
  • You do not have other skin conditions or wounds on your face that could affect the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06648447Recruiting
Testing tirbanibulin cream for certain actinic keratoses

This study tests whether tirbanibulin (Klisyri) cream works well on specific types of actinic keratosis on the scalp or face that have a downward growth pattern. It helps doctors understand if this treatment is right for those skin spots.

Wuppertal, North Rhine-Westphalia
NCT07729579Recruiting· Phase 1
Study of a drug for actinic keratosis on arms or face

This trial tests how a new drug works in people with actinic keratosis (rough, scaly patches caused by sun damage) on their upper arms or face. You will receive the treatment and have blood samples taken to see how your body processes the medication.

College Station, Texas
NCT07318675Recruiting· Phase 1
Testing an ointment for actinic keratosis on the face

This trial tests an ointment called HW211026 for people with actinic keratosis, a common skin condition caused by sun damage. The study will check if the ointment is safe and works when applied to a 10 cm by 10 cm area on the face.

Shanghai
NCT07335003Recruiting
Sunscreen study for preventing skin damage in older adults with actinic keratoses

This study tests a new sunscreen (Anthelos Fluide 100 KA+ UVMune 400) to see if it can protect skin and prevent further sun damage in people who already have multiple actinic keratoses (precancerous spots). It may help reduce the risk of new spots or skin cancer.

Camperdown, New South Wales
NCT07273656Not yet recruiting· Phase 3
Freezing plus tirbanibulin ointment for scaly spots on scalp or forehead

This trial tests whether freezing the spots (cryotherapy) followed by a medicated ointment (tirbanibulin) works better than freezing alone for actinic keratoses on the scalp and forehead. It may help you if you have many of these rough spots and want to see if the combination treatment works better.

NCT07144345Recruiting· Phase 3
Reformulated Light-Activated Cream for Actinic Keratosis on Face or Scalp

This trial tests a reformulated light-activated cream (Levulan Kerastick) for treating actinic keratosis (precancerous skin spots) on the face or bald scalp. It is a phase 3 study to see if the new version works better with fewer side effects.

Fremont, California

Hear when a new Actinic Keratosis (AK) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.